Biotech · Private company
Transcend Therapeutics
Track this companyFree. Adds Transcend Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials63 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- TSND-201Phase 3 · Post Traumatic Stress DisorderClinicalTrials.gov · fetched Nov 12, 2026
- MethylonePhase 2 · Post Traumatic Stress DisorderClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSDPHASE3 · RECRUITING · started Sep 25, 2026ClinicalTrials.gov NCT07836647 · fetched Nov 12, 2026
- An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSDPHASE3 · ENROLLING_BY_INVITATION · started Jun 22, 2026ClinicalTrials.gov NCT07670702 · fetched Nov 12, 2026
- An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)PHASE3 · RECRUITING · started Apr 2, 2026ClinicalTrials.gov NCT07456696 · fetched Nov 12, 2026
- An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSDPHASE2 · COMPLETED · started Apr 4, 2024ClinicalTrials.gov NCT06215261 · fetched Nov 12, 2026
- An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSDPHASE2 · COMPLETED · started Mar 6, 2024ClinicalTrials.gov NCT06237426 · fetched Nov 12, 2026
- A Study to Assess the Use of Methylone in the Treatment of PTSDPHASE1_PHASE2 · COMPLETED · started Mar 1, 2023ClinicalTrials.gov NCT05741710 · fetched Nov 12, 2026